Global Sumatriptan Supply, Demand and Key Producers, 2026-2032
The global Sumatriptan market size is expected to reach $ 786 million by 2032, rising at a market growth of 4.4% CAGR during the forecast period (2026-2032).
Sumatriptan is a finished pharmaceutical preparation within the triptan class of 5-HT1B/1D receptor agonists and represents one of the longest-established and clinically mature therapies for the acute treatment of migraine, with additional use in selected cases of cluster headache. Common dosage forms include oral tablets, subcutaneous injections, and nasal sprays, with tablets accounting for the largest share of global volume. Upstream inputs include sumatriptan API and related intermediates, excipients for oral and injectable formulations (such as microcrystalline cellulose, lactose, crospovidone, hypromellose, sterile water for injection, and buffering systems), as well as pharmaceutical packaging materials including blister packs, bottle systems, and prefilled syringe components. Manufacturing involves standardized processes such as granulation, compression, coating, aseptic compounding, and filling, under stringent quality and impurity control systems. Downstream customers comprise global and regional generic pharmaceutical manufacturers, hospital neurology and emergency departments, headache specialty clinics, retail pharmacy chains, and online prescription platforms. On a manufacturing ex-factory basis, global nominal capacity in 2025 is estimated at approximately 458 million tablets/units, with actual sales of about 394 million tablets/units (aggregated across tablet and injectable forms) and a weighted average ex-factory price of around USD 1.42 per tablet/unit; under intense generic competition and healthcare cost-containment pressures, manufacturing-level gross margin typically ranges from 27% to 37%.
Sumatriptan, as a representative drug within the triptan class, has entered a mature phase in the global market and is characterized by a highly competitive generic landscape. In most developed markets, patent protection has long expired, and supply is dominated by multiple generic manufacturers, resulting in transparent pricing structures and intense competition. Its clinical position in the acute treatment of migraine remains well established, particularly for patients requiring rapid symptom relief. However, evolving treatment paradigms and the increasing adoption of newer therapeutic mechanisms have led to structural pressure on traditional triptans in certain markets.
Looking ahead, the market for sumatriptan is more likely to demonstrate stability or gradual adjustment rather than significant expansion. The continued promotion of standardized migraine management supports baseline demand, especially in primary healthcare systems and emerging markets where triptans remain accessible and cost-effective first-line therapies. Improvements in auto-injector technologies and greater emphasis on patient self-management may help sustain demand for injectable formulations. Nevertheless, in developed countries, ongoing penetration of CGRP-targeted therapies and biologics is progressively reshaping treatment pathways.
Key market drivers include the persistent prevalence of migraine and improvements in diagnosis rates. Greater public awareness of neurological disorders and expanded healthcare access contribute to more standardized treatment practices. In addition, the established reimbursement positioning and relatively lower treatment costs of triptans allow them to retain competitiveness in cost-sensitive markets. From a production perspective, mature manufacturing processes and economies of scale support supply stability and manageable margin structures.
At the same time, the industry faces multiple constraints. The introduction of novel anti-migraine therapies exerts substitution pressure, particularly in high-income markets where treatment innovation is rapidly adopted. Healthcare cost-containment measures and centralized procurement policies continue to compress pricing and profitability. Furthermore, concerns regarding potential cardiovascular risks associated with triptans may limit their use in certain patient populations. Overall, the sumatriptan market is expected to reflect characteristics of a mature product category, marked by structural optimization and regional differentiation rather than rapid growth.
This report studies the global Sumatriptan production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Sumatriptan and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Sumatriptan that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Sumatriptan total production and demand, 2021-2032, (K Units)
Global Sumatriptan total production value, 2021-2032, (USD Million)
Global Sumatriptan production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Sumatriptan consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Sumatriptan domestic production, consumption, key domestic manufacturers and share
Global Sumatriptan production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Sumatriptan production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Sumatriptan production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Sumatriptan market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline, Dr Reddy's Laboratories, Teva Pharmaceutical Industries, Sun Pharmaceutical Industries, Prasco Laboratories, Lupin Laboratories, Viatris, Sawai Pharmaceutical, Aurobindo Pharma, Hunan Jiudian Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Sumatriptan market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Sumatriptan Market, By Region:
1. How big is the global Sumatriptan market?
2. What is the demand of the global Sumatriptan market?
3. What is the year over year growth of the global Sumatriptan market?
4. What is the production and production value of the global Sumatriptan market?
5. Who are the key producers in the global Sumatriptan market?
6. What are the growth factors driving the market demand?
Sumatriptan is a finished pharmaceutical preparation within the triptan class of 5-HT1B/1D receptor agonists and represents one of the longest-established and clinically mature therapies for the acute treatment of migraine, with additional use in selected cases of cluster headache. Common dosage forms include oral tablets, subcutaneous injections, and nasal sprays, with tablets accounting for the largest share of global volume. Upstream inputs include sumatriptan API and related intermediates, excipients for oral and injectable formulations (such as microcrystalline cellulose, lactose, crospovidone, hypromellose, sterile water for injection, and buffering systems), as well as pharmaceutical packaging materials including blister packs, bottle systems, and prefilled syringe components. Manufacturing involves standardized processes such as granulation, compression, coating, aseptic compounding, and filling, under stringent quality and impurity control systems. Downstream customers comprise global and regional generic pharmaceutical manufacturers, hospital neurology and emergency departments, headache specialty clinics, retail pharmacy chains, and online prescription platforms. On a manufacturing ex-factory basis, global nominal capacity in 2025 is estimated at approximately 458 million tablets/units, with actual sales of about 394 million tablets/units (aggregated across tablet and injectable forms) and a weighted average ex-factory price of around USD 1.42 per tablet/unit; under intense generic competition and healthcare cost-containment pressures, manufacturing-level gross margin typically ranges from 27% to 37%.
Sumatriptan, as a representative drug within the triptan class, has entered a mature phase in the global market and is characterized by a highly competitive generic landscape. In most developed markets, patent protection has long expired, and supply is dominated by multiple generic manufacturers, resulting in transparent pricing structures and intense competition. Its clinical position in the acute treatment of migraine remains well established, particularly for patients requiring rapid symptom relief. However, evolving treatment paradigms and the increasing adoption of newer therapeutic mechanisms have led to structural pressure on traditional triptans in certain markets.
Looking ahead, the market for sumatriptan is more likely to demonstrate stability or gradual adjustment rather than significant expansion. The continued promotion of standardized migraine management supports baseline demand, especially in primary healthcare systems and emerging markets where triptans remain accessible and cost-effective first-line therapies. Improvements in auto-injector technologies and greater emphasis on patient self-management may help sustain demand for injectable formulations. Nevertheless, in developed countries, ongoing penetration of CGRP-targeted therapies and biologics is progressively reshaping treatment pathways.
Key market drivers include the persistent prevalence of migraine and improvements in diagnosis rates. Greater public awareness of neurological disorders and expanded healthcare access contribute to more standardized treatment practices. In addition, the established reimbursement positioning and relatively lower treatment costs of triptans allow them to retain competitiveness in cost-sensitive markets. From a production perspective, mature manufacturing processes and economies of scale support supply stability and manageable margin structures.
At the same time, the industry faces multiple constraints. The introduction of novel anti-migraine therapies exerts substitution pressure, particularly in high-income markets where treatment innovation is rapidly adopted. Healthcare cost-containment measures and centralized procurement policies continue to compress pricing and profitability. Furthermore, concerns regarding potential cardiovascular risks associated with triptans may limit their use in certain patient populations. Overall, the sumatriptan market is expected to reflect characteristics of a mature product category, marked by structural optimization and regional differentiation rather than rapid growth.
This report studies the global Sumatriptan production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Sumatriptan and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Sumatriptan that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Sumatriptan total production and demand, 2021-2032, (K Units)
Global Sumatriptan total production value, 2021-2032, (USD Million)
Global Sumatriptan production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Sumatriptan consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Sumatriptan domestic production, consumption, key domestic manufacturers and share
Global Sumatriptan production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Sumatriptan production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Sumatriptan production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Sumatriptan market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline, Dr Reddy's Laboratories, Teva Pharmaceutical Industries, Sun Pharmaceutical Industries, Prasco Laboratories, Lupin Laboratories, Viatris, Sawai Pharmaceutical, Aurobindo Pharma, Hunan Jiudian Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Sumatriptan market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Sumatriptan Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Tablets
- Injections
- Others
- Originator Product
- Generic Product
- Acute Migraine
- Acute Cluster Headache
- Others
- Hospital
- Retail Pharmacies
- Others
- GlaxoSmithKline
- Dr Reddy's Laboratories
- Teva Pharmaceutical Industries
- Sun Pharmaceutical Industries
- Prasco Laboratories
- Lupin Laboratories
- Viatris
- Sawai Pharmaceutical
- Aurobindo Pharma
- Hunan Jiudian Pharmaceutical
- Simcere Pharmaceutical
1. How big is the global Sumatriptan market?
2. What is the demand of the global Sumatriptan market?
3. What is the year over year growth of the global Sumatriptan market?
4. What is the production and production value of the global Sumatriptan market?
5. Who are the key producers in the global Sumatriptan market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Sumatriptan Introduction
1.2 World Sumatriptan Supply & Forecast
1.2.1 World Sumatriptan Production Value (2021 & 2025 & 2032)
1.2.2 World Sumatriptan Production (2021-2032)
1.2.3 World Sumatriptan Pricing Trends (2021-2032)
1.3 World Sumatriptan Production by Region (Based on Production Site)
1.3.1 World Sumatriptan Production Value by Region (2021-2032)
1.3.2 World Sumatriptan Production by Region (2021-2032)
1.3.3 World Sumatriptan Average Price by Region (2021-2032)
1.3.4 North America Sumatriptan Production (2021-2032)
1.3.5 Europe Sumatriptan Production (2021-2032)
1.3.6 China Sumatriptan Production (2021-2032)
1.3.7 Japan Sumatriptan Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Sumatriptan Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Sumatriptan Major Market Trends
2 DEMAND SUMMARY
2.1 World Sumatriptan Demand (2021-2032)
2.2 World Sumatriptan Consumption by Region
2.2.1 World Sumatriptan Consumption by Region (2021-2026)
2.2.2 World Sumatriptan Consumption Forecast by Region (2027-2032)
2.3 United States Sumatriptan Consumption (2021-2032)
2.4 China Sumatriptan Consumption (2021-2032)
2.5 Europe Sumatriptan Consumption (2021-2032)
2.6 Japan Sumatriptan Consumption (2021-2032)
2.7 South Korea Sumatriptan Consumption (2021-2032)
2.8 ASEAN Sumatriptan Consumption (2021-2032)
2.9 India Sumatriptan Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Sumatriptan Production Value by Manufacturer (2021-2026)
3.2 World Sumatriptan Production by Manufacturer (2021-2026)
3.3 World Sumatriptan Average Price by Manufacturer (2021-2026)
3.4 Sumatriptan Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Sumatriptan Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Sumatriptan in 2025
3.5.3 Global Concentration Ratios (CR8) for Sumatriptan in 2025
3.6 Sumatriptan Market: Overall Company Footprint Analysis
3.6.1 Sumatriptan Market: Region Footprint
3.6.2 Sumatriptan Market: Company Product Type Footprint
3.6.3 Sumatriptan Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Sumatriptan Production Value Comparison
4.1.1 United States VS China: Sumatriptan Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Sumatriptan Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Sumatriptan Production Comparison
4.2.1 United States VS China: Sumatriptan Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Sumatriptan Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Sumatriptan Consumption Comparison
4.3.1 United States VS China: Sumatriptan Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Sumatriptan Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Sumatriptan Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Sumatriptan Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Sumatriptan Production Value (2021-2026)
4.4.3 United States Based Manufacturers Sumatriptan Production (2021-2026)
4.5 China Based Sumatriptan Manufacturers and Market Share
4.5.1 China Based Sumatriptan Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Sumatriptan Production Value (2021-2026)
4.5.3 China Based Manufacturers Sumatriptan Production (2021-2026)
4.6 Rest of World Based Sumatriptan Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Sumatriptan Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Sumatriptan Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Sumatriptan Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Sumatriptan Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Tablets
5.2.2 Injections
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Sumatriptan Production by Type (2021-2032)
5.3.2 World Sumatriptan Production Value by Type (2021-2032)
5.3.3 World Sumatriptan Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY REGULATORY STATUS
6.1 World Sumatriptan Market Size Overview by Regulatory Status: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Regulatory Status
6.2.1 Originator Product
6.2.2 Generic Product
6.3 Market Segment by Regulatory Status
6.3.1 World Sumatriptan Production by Regulatory Status (2021-2032)
6.3.2 World Sumatriptan Production Value by Regulatory Status (2021-2032)
6.3.3 World Sumatriptan Average Price by Regulatory Status (2021-2032)
7 MARKET ANALYSIS BY CLINICAL APPLICATION
7.1 World Sumatriptan Market Size Overview by Clinical Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Clinical Application
7.2.1 Acute Migraine
7.2.2 Acute Cluster Headache
7.2.3 Others
7.3 Market Segment by Clinical Application
7.3.1 World Sumatriptan Production by Clinical Application (2021-2032)
7.3.2 World Sumatriptan Production Value by Clinical Application (2021-2032)
7.3.3 World Sumatriptan Average Price by Clinical Application (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Sumatriptan Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Retail Pharmacies
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Sumatriptan Production by Application (2021-2032)
8.3.2 World Sumatriptan Production Value by Application (2021-2032)
8.3.3 World Sumatriptan Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 GlaxoSmithKline
9.1.1 GlaxoSmithKline Details
9.1.2 GlaxoSmithKline Major Business
9.1.3 GlaxoSmithKline Sumatriptan Product and Services
9.1.4 GlaxoSmithKline Sumatriptan Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 GlaxoSmithKline Recent Developments/Updates
9.1.6 GlaxoSmithKline Competitive Strengths & Weaknesses
9.2 Dr Reddy's Laboratories
9.2.1 Dr Reddy's Laboratories Details
9.2.2 Dr Reddy's Laboratories Major Business
9.2.3 Dr Reddy's Laboratories Sumatriptan Product and Services
9.2.4 Dr Reddy's Laboratories Sumatriptan Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Dr Reddy's Laboratories Recent Developments/Updates
9.2.6 Dr Reddy's Laboratories Competitive Strengths & Weaknesses
9.3 Teva Pharmaceutical Industries
9.3.1 Teva Pharmaceutical Industries Details
9.3.2 Teva Pharmaceutical Industries Major Business
9.3.3 Teva Pharmaceutical Industries Sumatriptan Product and Services
9.3.4 Teva Pharmaceutical Industries Sumatriptan Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Teva Pharmaceutical Industries Recent Developments/Updates
9.3.6 Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
9.4 Sun Pharmaceutical Industries
9.4.1 Sun Pharmaceutical Industries Details
9.4.2 Sun Pharmaceutical Industries Major Business
9.4.3 Sun Pharmaceutical Industries Sumatriptan Product and Services
9.4.4 Sun Pharmaceutical Industries Sumatriptan Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Sun Pharmaceutical Industries Recent Developments/Updates
9.4.6 Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
9.5 Prasco Laboratories
9.5.1 Prasco Laboratories Details
9.5.2 Prasco Laboratories Major Business
9.5.3 Prasco Laboratories Sumatriptan Product and Services
9.5.4 Prasco Laboratories Sumatriptan Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Prasco Laboratories Recent Developments/Updates
9.5.6 Prasco Laboratories Competitive Strengths & Weaknesses
9.6 Lupin Laboratories
9.6.1 Lupin Laboratories Details
9.6.2 Lupin Laboratories Major Business
9.6.3 Lupin Laboratories Sumatriptan Product and Services
9.6.4 Lupin Laboratories Sumatriptan Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Lupin Laboratories Recent Developments/Updates
9.6.6 Lupin Laboratories Competitive Strengths & Weaknesses
9.7 Viatris
9.7.1 Viatris Details
9.7.2 Viatris Major Business
9.7.3 Viatris Sumatriptan Product and Services
9.7.4 Viatris Sumatriptan Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Viatris Recent Developments/Updates
9.7.6 Viatris Competitive Strengths & Weaknesses
9.8 Sawai Pharmaceutical
9.8.1 Sawai Pharmaceutical Details
9.8.2 Sawai Pharmaceutical Major Business
9.8.3 Sawai Pharmaceutical Sumatriptan Product and Services
9.8.4 Sawai Pharmaceutical Sumatriptan Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Sawai Pharmaceutical Recent Developments/Updates
9.8.6 Sawai Pharmaceutical Competitive Strengths & Weaknesses
9.9 Aurobindo Pharma
9.9.1 Aurobindo Pharma Details
9.9.2 Aurobindo Pharma Major Business
9.9.3 Aurobindo Pharma Sumatriptan Product and Services
9.9.4 Aurobindo Pharma Sumatriptan Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Aurobindo Pharma Recent Developments/Updates
9.9.6 Aurobindo Pharma Competitive Strengths & Weaknesses
9.10 Hunan Jiudian Pharmaceutical
9.10.1 Hunan Jiudian Pharmaceutical Details
9.10.2 Hunan Jiudian Pharmaceutical Major Business
9.10.3 Hunan Jiudian Pharmaceutical Sumatriptan Product and Services
9.10.4 Hunan Jiudian Pharmaceutical Sumatriptan Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Hunan Jiudian Pharmaceutical Recent Developments/Updates
9.10.6 Hunan Jiudian Pharmaceutical Competitive Strengths & Weaknesses
9.11 Simcere Pharmaceutical
9.11.1 Simcere Pharmaceutical Details
9.11.2 Simcere Pharmaceutical Major Business
9.11.3 Simcere Pharmaceutical Sumatriptan Product and Services
9.11.4 Simcere Pharmaceutical Sumatriptan Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Simcere Pharmaceutical Recent Developments/Updates
9.11.6 Simcere Pharmaceutical Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Sumatriptan Industry Chain
10.2 Sumatriptan Upstream Analysis
10.2.1 Sumatriptan Core Raw Materials
10.2.2 Main Manufacturers of Sumatriptan Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Sumatriptan Production Mode
10.6 Sumatriptan Procurement Model
10.7 Sumatriptan Industry Sales Model and Sales Channels
10.7.1 Sumatriptan Sales Model
10.7.2 Sumatriptan Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Sumatriptan Introduction
1.2 World Sumatriptan Supply & Forecast
1.2.1 World Sumatriptan Production Value (2021 & 2025 & 2032)
1.2.2 World Sumatriptan Production (2021-2032)
1.2.3 World Sumatriptan Pricing Trends (2021-2032)
1.3 World Sumatriptan Production by Region (Based on Production Site)
1.3.1 World Sumatriptan Production Value by Region (2021-2032)
1.3.2 World Sumatriptan Production by Region (2021-2032)
1.3.3 World Sumatriptan Average Price by Region (2021-2032)
1.3.4 North America Sumatriptan Production (2021-2032)
1.3.5 Europe Sumatriptan Production (2021-2032)
1.3.6 China Sumatriptan Production (2021-2032)
1.3.7 Japan Sumatriptan Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Sumatriptan Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Sumatriptan Major Market Trends
2 DEMAND SUMMARY
2.1 World Sumatriptan Demand (2021-2032)
2.2 World Sumatriptan Consumption by Region
2.2.1 World Sumatriptan Consumption by Region (2021-2026)
2.2.2 World Sumatriptan Consumption Forecast by Region (2027-2032)
2.3 United States Sumatriptan Consumption (2021-2032)
2.4 China Sumatriptan Consumption (2021-2032)
2.5 Europe Sumatriptan Consumption (2021-2032)
2.6 Japan Sumatriptan Consumption (2021-2032)
2.7 South Korea Sumatriptan Consumption (2021-2032)
2.8 ASEAN Sumatriptan Consumption (2021-2032)
2.9 India Sumatriptan Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Sumatriptan Production Value by Manufacturer (2021-2026)
3.2 World Sumatriptan Production by Manufacturer (2021-2026)
3.3 World Sumatriptan Average Price by Manufacturer (2021-2026)
3.4 Sumatriptan Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Sumatriptan Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Sumatriptan in 2025
3.5.3 Global Concentration Ratios (CR8) for Sumatriptan in 2025
3.6 Sumatriptan Market: Overall Company Footprint Analysis
3.6.1 Sumatriptan Market: Region Footprint
3.6.2 Sumatriptan Market: Company Product Type Footprint
3.6.3 Sumatriptan Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Sumatriptan Production Value Comparison
4.1.1 United States VS China: Sumatriptan Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Sumatriptan Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Sumatriptan Production Comparison
4.2.1 United States VS China: Sumatriptan Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Sumatriptan Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Sumatriptan Consumption Comparison
4.3.1 United States VS China: Sumatriptan Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Sumatriptan Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Sumatriptan Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Sumatriptan Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Sumatriptan Production Value (2021-2026)
4.4.3 United States Based Manufacturers Sumatriptan Production (2021-2026)
4.5 China Based Sumatriptan Manufacturers and Market Share
4.5.1 China Based Sumatriptan Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Sumatriptan Production Value (2021-2026)
4.5.3 China Based Manufacturers Sumatriptan Production (2021-2026)
4.6 Rest of World Based Sumatriptan Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Sumatriptan Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Sumatriptan Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Sumatriptan Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Sumatriptan Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Tablets
5.2.2 Injections
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Sumatriptan Production by Type (2021-2032)
5.3.2 World Sumatriptan Production Value by Type (2021-2032)
5.3.3 World Sumatriptan Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY REGULATORY STATUS
6.1 World Sumatriptan Market Size Overview by Regulatory Status: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Regulatory Status
6.2.1 Originator Product
6.2.2 Generic Product
6.3 Market Segment by Regulatory Status
6.3.1 World Sumatriptan Production by Regulatory Status (2021-2032)
6.3.2 World Sumatriptan Production Value by Regulatory Status (2021-2032)
6.3.3 World Sumatriptan Average Price by Regulatory Status (2021-2032)
7 MARKET ANALYSIS BY CLINICAL APPLICATION
7.1 World Sumatriptan Market Size Overview by Clinical Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Clinical Application
7.2.1 Acute Migraine
7.2.2 Acute Cluster Headache
7.2.3 Others
7.3 Market Segment by Clinical Application
7.3.1 World Sumatriptan Production by Clinical Application (2021-2032)
7.3.2 World Sumatriptan Production Value by Clinical Application (2021-2032)
7.3.3 World Sumatriptan Average Price by Clinical Application (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Sumatriptan Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Retail Pharmacies
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Sumatriptan Production by Application (2021-2032)
8.3.2 World Sumatriptan Production Value by Application (2021-2032)
8.3.3 World Sumatriptan Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 GlaxoSmithKline
9.1.1 GlaxoSmithKline Details
9.1.2 GlaxoSmithKline Major Business
9.1.3 GlaxoSmithKline Sumatriptan Product and Services
9.1.4 GlaxoSmithKline Sumatriptan Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 GlaxoSmithKline Recent Developments/Updates
9.1.6 GlaxoSmithKline Competitive Strengths & Weaknesses
9.2 Dr Reddy's Laboratories
9.2.1 Dr Reddy's Laboratories Details
9.2.2 Dr Reddy's Laboratories Major Business
9.2.3 Dr Reddy's Laboratories Sumatriptan Product and Services
9.2.4 Dr Reddy's Laboratories Sumatriptan Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Dr Reddy's Laboratories Recent Developments/Updates
9.2.6 Dr Reddy's Laboratories Competitive Strengths & Weaknesses
9.3 Teva Pharmaceutical Industries
9.3.1 Teva Pharmaceutical Industries Details
9.3.2 Teva Pharmaceutical Industries Major Business
9.3.3 Teva Pharmaceutical Industries Sumatriptan Product and Services
9.3.4 Teva Pharmaceutical Industries Sumatriptan Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Teva Pharmaceutical Industries Recent Developments/Updates
9.3.6 Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
9.4 Sun Pharmaceutical Industries
9.4.1 Sun Pharmaceutical Industries Details
9.4.2 Sun Pharmaceutical Industries Major Business
9.4.3 Sun Pharmaceutical Industries Sumatriptan Product and Services
9.4.4 Sun Pharmaceutical Industries Sumatriptan Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Sun Pharmaceutical Industries Recent Developments/Updates
9.4.6 Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
9.5 Prasco Laboratories
9.5.1 Prasco Laboratories Details
9.5.2 Prasco Laboratories Major Business
9.5.3 Prasco Laboratories Sumatriptan Product and Services
9.5.4 Prasco Laboratories Sumatriptan Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Prasco Laboratories Recent Developments/Updates
9.5.6 Prasco Laboratories Competitive Strengths & Weaknesses
9.6 Lupin Laboratories
9.6.1 Lupin Laboratories Details
9.6.2 Lupin Laboratories Major Business
9.6.3 Lupin Laboratories Sumatriptan Product and Services
9.6.4 Lupin Laboratories Sumatriptan Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Lupin Laboratories Recent Developments/Updates
9.6.6 Lupin Laboratories Competitive Strengths & Weaknesses
9.7 Viatris
9.7.1 Viatris Details
9.7.2 Viatris Major Business
9.7.3 Viatris Sumatriptan Product and Services
9.7.4 Viatris Sumatriptan Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Viatris Recent Developments/Updates
9.7.6 Viatris Competitive Strengths & Weaknesses
9.8 Sawai Pharmaceutical
9.8.1 Sawai Pharmaceutical Details
9.8.2 Sawai Pharmaceutical Major Business
9.8.3 Sawai Pharmaceutical Sumatriptan Product and Services
9.8.4 Sawai Pharmaceutical Sumatriptan Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Sawai Pharmaceutical Recent Developments/Updates
9.8.6 Sawai Pharmaceutical Competitive Strengths & Weaknesses
9.9 Aurobindo Pharma
9.9.1 Aurobindo Pharma Details
9.9.2 Aurobindo Pharma Major Business
9.9.3 Aurobindo Pharma Sumatriptan Product and Services
9.9.4 Aurobindo Pharma Sumatriptan Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Aurobindo Pharma Recent Developments/Updates
9.9.6 Aurobindo Pharma Competitive Strengths & Weaknesses
9.10 Hunan Jiudian Pharmaceutical
9.10.1 Hunan Jiudian Pharmaceutical Details
9.10.2 Hunan Jiudian Pharmaceutical Major Business
9.10.3 Hunan Jiudian Pharmaceutical Sumatriptan Product and Services
9.10.4 Hunan Jiudian Pharmaceutical Sumatriptan Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Hunan Jiudian Pharmaceutical Recent Developments/Updates
9.10.6 Hunan Jiudian Pharmaceutical Competitive Strengths & Weaknesses
9.11 Simcere Pharmaceutical
9.11.1 Simcere Pharmaceutical Details
9.11.2 Simcere Pharmaceutical Major Business
9.11.3 Simcere Pharmaceutical Sumatriptan Product and Services
9.11.4 Simcere Pharmaceutical Sumatriptan Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Simcere Pharmaceutical Recent Developments/Updates
9.11.6 Simcere Pharmaceutical Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Sumatriptan Industry Chain
10.2 Sumatriptan Upstream Analysis
10.2.1 Sumatriptan Core Raw Materials
10.2.2 Main Manufacturers of Sumatriptan Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Sumatriptan Production Mode
10.6 Sumatriptan Procurement Model
10.7 Sumatriptan Industry Sales Model and Sales Channels
10.7.1 Sumatriptan Sales Model
10.7.2 Sumatriptan Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Sumatriptan Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Sumatriptan Production Value by Region (2021-2026) & (USD Million)
Table 3. World Sumatriptan Production Value by Region (2027-2032) & (USD Million)
Table 4. World Sumatriptan Production Value Market Share by Region (2021-2026)
Table 5. World Sumatriptan Production Value Market Share by Region (2027-2032)
Table 6. World Sumatriptan Production by Region (2021-2026) & (K Units)
Table 7. World Sumatriptan Production by Region (2027-2032) & (K Units)
Table 8. World Sumatriptan Production Market Share by Region (2021-2026)
Table 9. World Sumatriptan Production Market Share by Region (2027-2032)
Table 10. World Sumatriptan Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Sumatriptan Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Sumatriptan Major Market Trends
Table 13. World Sumatriptan Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Sumatriptan Consumption by Region (2021-2026) & (K Units)
Table 15. World Sumatriptan Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Sumatriptan Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Sumatriptan Producers in 2025
Table 18. World Sumatriptan Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Sumatriptan Producers in 2025
Table 20. World Sumatriptan Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Sumatriptan Company Evaluation Quadrant
Table 22. World Sumatriptan Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Sumatriptan Production Site of Key Manufacturer
Table 24. Sumatriptan Market: Company Product Type Footprint
Table 25. Sumatriptan Market: Company Product Application Footprint
Table 26. Sumatriptan Competitive Factors
Table 27. Sumatriptan New Entrant and Capacity Expansion Plans
Table 28. Sumatriptan Mergers & Acquisitions Activity
Table 29. United States VS China Sumatriptan Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Sumatriptan Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Sumatriptan Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Sumatriptan Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Sumatriptan Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Sumatriptan Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Sumatriptan Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Sumatriptan Production Market Share (2021-2026)
Table 37. China Based Sumatriptan Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Sumatriptan Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Sumatriptan Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Sumatriptan Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Sumatriptan Production Market Share (2021-2026)
Table 42. Rest of World Based Sumatriptan Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Sumatriptan Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Sumatriptan Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Sumatriptan Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Sumatriptan Production Market Share (2021-2026)
Table 47. World Sumatriptan Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Sumatriptan Production by Type (2021-2026) & (K Units)
Table 49. World Sumatriptan Production by Type (2027-2032) & (K Units)
Table 50. World Sumatriptan Production Value by Type (2021-2026) & (USD Million)
Table 51. World Sumatriptan Production Value by Type (2027-2032) & (USD Million)
Table 52. World Sumatriptan Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Sumatriptan Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Sumatriptan Production Value by Regulatory Status, (USD Million), 2021 & 2025 & 2032
Table 55. World Sumatriptan Production by Regulatory Status (2021-2026) & (K Units)
Table 56. World Sumatriptan Production by Regulatory Status (2027-2032) & (K Units)
Table 57. World Sumatriptan Production Value by Regulatory Status (2021-2026) & (USD Million)
Table 58. World Sumatriptan Production Value by Regulatory Status (2027-2032) & (USD Million)
Table 59. World Sumatriptan Average Price by Regulatory Status (2021-2026) & (US$/Unit)
Table 60. World Sumatriptan Average Price by Regulatory Status (2027-2032) & (US$/Unit)
Table 61. World Sumatriptan Production Value by Clinical Application, (USD Million), 2021 & 2025 & 2032
Table 62. World Sumatriptan Production by Clinical Application (2021-2026) & (K Units)
Table 63. World Sumatriptan Production by Clinical Application (2027-2032) & (K Units)
Table 64. World Sumatriptan Production Value by Clinical Application (2021-2026) & (USD Million)
Table 65. World Sumatriptan Production Value by Clinical Application (2027-2032) & (USD Million)
Table 66. World Sumatriptan Average Price by Clinical Application (2021-2026) & (US$/Unit)
Table 67. World Sumatriptan Average Price by Clinical Application (2027-2032) & (US$/Unit)
Table 68. World Sumatriptan Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Sumatriptan Production by Application (2021-2026) & (K Units)
Table 70. World Sumatriptan Production by Application (2027-2032) & (K Units)
Table 71. World Sumatriptan Production Value by Application (2021-2026) & (USD Million)
Table 72. World Sumatriptan Production Value by Application (2027-2032) & (USD Million)
Table 73. World Sumatriptan Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Sumatriptan Average Price by Application (2027-2032) & (US$/Unit)
Table 75. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 76. GlaxoSmithKline Major Business
Table 77. GlaxoSmithKline Sumatriptan Product and Services
Table 78. GlaxoSmithKline Sumatriptan Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. GlaxoSmithKline Recent Developments/Updates
Table 80. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 81. Dr Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 82. Dr Reddy's Laboratories Major Business
Table 83. Dr Reddy's Laboratories Sumatriptan Product and Services
Table 84. Dr Reddy's Laboratories Sumatriptan Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Dr Reddy's Laboratories Recent Developments/Updates
Table 86. Dr Reddy's Laboratories Competitive Strengths & Weaknesses
Table 87. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 88. Teva Pharmaceutical Industries Major Business
Table 89. Teva Pharmaceutical Industries Sumatriptan Product and Services
Table 90. Teva Pharmaceutical Industries Sumatriptan Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Teva Pharmaceutical Industries Recent Developments/Updates
Table 92. Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 93. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 94. Sun Pharmaceutical Industries Major Business
Table 95. Sun Pharmaceutical Industries Sumatriptan Product and Services
Table 96. Sun Pharmaceutical Industries Sumatriptan Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Sun Pharmaceutical Industries Recent Developments/Updates
Table 98. Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 99. Prasco Laboratories Basic Information, Manufacturing Base and Competitors
Table 100. Prasco Laboratories Major Business
Table 101. Prasco Laboratories Sumatriptan Product and Services
Table 102. Prasco Laboratories Sumatriptan Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Prasco Laboratories Recent Developments/Updates
Table 104. Prasco Laboratories Competitive Strengths & Weaknesses
Table 105. Lupin Laboratories Basic Information, Manufacturing Base and Competitors
Table 106. Lupin Laboratories Major Business
Table 107. Lupin Laboratories Sumatriptan Product and Services
Table 108. Lupin Laboratories Sumatriptan Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Lupin Laboratories Recent Developments/Updates
Table 110. Lupin Laboratories Competitive Strengths & Weaknesses
Table 111. Viatris Basic Information, Manufacturing Base and Competitors
Table 112. Viatris Major Business
Table 113. Viatris Sumatriptan Product and Services
Table 114. Viatris Sumatriptan Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Viatris Recent Developments/Updates
Table 116. Viatris Competitive Strengths & Weaknesses
Table 117. Sawai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 118. Sawai Pharmaceutical Major Business
Table 119. Sawai Pharmaceutical Sumatriptan Product and Services
Table 120. Sawai Pharmaceutical Sumatriptan Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Sawai Pharmaceutical Recent Developments/Updates
Table 122. Sawai Pharmaceutical Competitive Strengths & Weaknesses
Table 123. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 124. Aurobindo Pharma Major Business
Table 125. Aurobindo Pharma Sumatriptan Product and Services
Table 126. Aurobindo Pharma Sumatriptan Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Aurobindo Pharma Recent Developments/Updates
Table 128. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 129. Hunan Jiudian Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 130. Hunan Jiudian Pharmaceutical Major Business
Table 131. Hunan Jiudian Pharmaceutical Sumatriptan Product and Services
Table 132. Hunan Jiudian Pharmaceutical Sumatriptan Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Hunan Jiudian Pharmaceutical Recent Developments/Updates
Table 134. Hunan Jiudian Pharmaceutical Competitive Strengths & Weaknesses
Table 135. Simcere Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 136. Simcere Pharmaceutical Major Business
Table 137. Simcere Pharmaceutical Sumatriptan Product and Services
Table 138. Simcere Pharmaceutical Sumatriptan Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Simcere Pharmaceutical Recent Developments/Updates
Table 140. Simcere Pharmaceutical Competitive Strengths & Weaknesses
Table 141. Global Key Players of Sumatriptan Upstream (Raw Materials)
Table 142. Global Sumatriptan Typical Customers
Table 143. Sumatriptan Typical Distributors
Table 1. World Sumatriptan Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Sumatriptan Production Value by Region (2021-2026) & (USD Million)
Table 3. World Sumatriptan Production Value by Region (2027-2032) & (USD Million)
Table 4. World Sumatriptan Production Value Market Share by Region (2021-2026)
Table 5. World Sumatriptan Production Value Market Share by Region (2027-2032)
Table 6. World Sumatriptan Production by Region (2021-2026) & (K Units)
Table 7. World Sumatriptan Production by Region (2027-2032) & (K Units)
Table 8. World Sumatriptan Production Market Share by Region (2021-2026)
Table 9. World Sumatriptan Production Market Share by Region (2027-2032)
Table 10. World Sumatriptan Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Sumatriptan Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Sumatriptan Major Market Trends
Table 13. World Sumatriptan Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Sumatriptan Consumption by Region (2021-2026) & (K Units)
Table 15. World Sumatriptan Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Sumatriptan Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Sumatriptan Producers in 2025
Table 18. World Sumatriptan Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Sumatriptan Producers in 2025
Table 20. World Sumatriptan Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Sumatriptan Company Evaluation Quadrant
Table 22. World Sumatriptan Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Sumatriptan Production Site of Key Manufacturer
Table 24. Sumatriptan Market: Company Product Type Footprint
Table 25. Sumatriptan Market: Company Product Application Footprint
Table 26. Sumatriptan Competitive Factors
Table 27. Sumatriptan New Entrant and Capacity Expansion Plans
Table 28. Sumatriptan Mergers & Acquisitions Activity
Table 29. United States VS China Sumatriptan Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Sumatriptan Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Sumatriptan Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Sumatriptan Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Sumatriptan Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Sumatriptan Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Sumatriptan Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Sumatriptan Production Market Share (2021-2026)
Table 37. China Based Sumatriptan Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Sumatriptan Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Sumatriptan Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Sumatriptan Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Sumatriptan Production Market Share (2021-2026)
Table 42. Rest of World Based Sumatriptan Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Sumatriptan Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Sumatriptan Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Sumatriptan Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Sumatriptan Production Market Share (2021-2026)
Table 47. World Sumatriptan Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Sumatriptan Production by Type (2021-2026) & (K Units)
Table 49. World Sumatriptan Production by Type (2027-2032) & (K Units)
Table 50. World Sumatriptan Production Value by Type (2021-2026) & (USD Million)
Table 51. World Sumatriptan Production Value by Type (2027-2032) & (USD Million)
Table 52. World Sumatriptan Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Sumatriptan Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Sumatriptan Production Value by Regulatory Status, (USD Million), 2021 & 2025 & 2032
Table 55. World Sumatriptan Production by Regulatory Status (2021-2026) & (K Units)
Table 56. World Sumatriptan Production by Regulatory Status (2027-2032) & (K Units)
Table 57. World Sumatriptan Production Value by Regulatory Status (2021-2026) & (USD Million)
Table 58. World Sumatriptan Production Value by Regulatory Status (2027-2032) & (USD Million)
Table 59. World Sumatriptan Average Price by Regulatory Status (2021-2026) & (US$/Unit)
Table 60. World Sumatriptan Average Price by Regulatory Status (2027-2032) & (US$/Unit)
Table 61. World Sumatriptan Production Value by Clinical Application, (USD Million), 2021 & 2025 & 2032
Table 62. World Sumatriptan Production by Clinical Application (2021-2026) & (K Units)
Table 63. World Sumatriptan Production by Clinical Application (2027-2032) & (K Units)
Table 64. World Sumatriptan Production Value by Clinical Application (2021-2026) & (USD Million)
Table 65. World Sumatriptan Production Value by Clinical Application (2027-2032) & (USD Million)
Table 66. World Sumatriptan Average Price by Clinical Application (2021-2026) & (US$/Unit)
Table 67. World Sumatriptan Average Price by Clinical Application (2027-2032) & (US$/Unit)
Table 68. World Sumatriptan Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Sumatriptan Production by Application (2021-2026) & (K Units)
Table 70. World Sumatriptan Production by Application (2027-2032) & (K Units)
Table 71. World Sumatriptan Production Value by Application (2021-2026) & (USD Million)
Table 72. World Sumatriptan Production Value by Application (2027-2032) & (USD Million)
Table 73. World Sumatriptan Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Sumatriptan Average Price by Application (2027-2032) & (US$/Unit)
Table 75. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 76. GlaxoSmithKline Major Business
Table 77. GlaxoSmithKline Sumatriptan Product and Services
Table 78. GlaxoSmithKline Sumatriptan Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. GlaxoSmithKline Recent Developments/Updates
Table 80. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 81. Dr Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 82. Dr Reddy's Laboratories Major Business
Table 83. Dr Reddy's Laboratories Sumatriptan Product and Services
Table 84. Dr Reddy's Laboratories Sumatriptan Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Dr Reddy's Laboratories Recent Developments/Updates
Table 86. Dr Reddy's Laboratories Competitive Strengths & Weaknesses
Table 87. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 88. Teva Pharmaceutical Industries Major Business
Table 89. Teva Pharmaceutical Industries Sumatriptan Product and Services
Table 90. Teva Pharmaceutical Industries Sumatriptan Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Teva Pharmaceutical Industries Recent Developments/Updates
Table 92. Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 93. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 94. Sun Pharmaceutical Industries Major Business
Table 95. Sun Pharmaceutical Industries Sumatriptan Product and Services
Table 96. Sun Pharmaceutical Industries Sumatriptan Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Sun Pharmaceutical Industries Recent Developments/Updates
Table 98. Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 99. Prasco Laboratories Basic Information, Manufacturing Base and Competitors
Table 100. Prasco Laboratories Major Business
Table 101. Prasco Laboratories Sumatriptan Product and Services
Table 102. Prasco Laboratories Sumatriptan Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Prasco Laboratories Recent Developments/Updates
Table 104. Prasco Laboratories Competitive Strengths & Weaknesses
Table 105. Lupin Laboratories Basic Information, Manufacturing Base and Competitors
Table 106. Lupin Laboratories Major Business
Table 107. Lupin Laboratories Sumatriptan Product and Services
Table 108. Lupin Laboratories Sumatriptan Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Lupin Laboratories Recent Developments/Updates
Table 110. Lupin Laboratories Competitive Strengths & Weaknesses
Table 111. Viatris Basic Information, Manufacturing Base and Competitors
Table 112. Viatris Major Business
Table 113. Viatris Sumatriptan Product and Services
Table 114. Viatris Sumatriptan Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Viatris Recent Developments/Updates
Table 116. Viatris Competitive Strengths & Weaknesses
Table 117. Sawai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 118. Sawai Pharmaceutical Major Business
Table 119. Sawai Pharmaceutical Sumatriptan Product and Services
Table 120. Sawai Pharmaceutical Sumatriptan Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Sawai Pharmaceutical Recent Developments/Updates
Table 122. Sawai Pharmaceutical Competitive Strengths & Weaknesses
Table 123. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 124. Aurobindo Pharma Major Business
Table 125. Aurobindo Pharma Sumatriptan Product and Services
Table 126. Aurobindo Pharma Sumatriptan Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Aurobindo Pharma Recent Developments/Updates
Table 128. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 129. Hunan Jiudian Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 130. Hunan Jiudian Pharmaceutical Major Business
Table 131. Hunan Jiudian Pharmaceutical Sumatriptan Product and Services
Table 132. Hunan Jiudian Pharmaceutical Sumatriptan Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Hunan Jiudian Pharmaceutical Recent Developments/Updates
Table 134. Hunan Jiudian Pharmaceutical Competitive Strengths & Weaknesses
Table 135. Simcere Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 136. Simcere Pharmaceutical Major Business
Table 137. Simcere Pharmaceutical Sumatriptan Product and Services
Table 138. Simcere Pharmaceutical Sumatriptan Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Simcere Pharmaceutical Recent Developments/Updates
Table 140. Simcere Pharmaceutical Competitive Strengths & Weaknesses
Table 141. Global Key Players of Sumatriptan Upstream (Raw Materials)
Table 142. Global Sumatriptan Typical Customers
Table 143. Sumatriptan Typical Distributors
LIST OF FIGURES
Figure 1. Sumatriptan Picture
Figure 2. World Sumatriptan Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Sumatriptan Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Sumatriptan Production (2021-2032) & (K Units)
Figure 5. World Sumatriptan Average Price (2021-2032) & (US$/Unit)
Figure 6. World Sumatriptan Production Value Market Share by Region (2021-2032)
Figure 7. World Sumatriptan Production Market Share by Region (2021-2032)
Figure 8. North America Sumatriptan Production (2021-2032) & (K Units)
Figure 9. Europe Sumatriptan Production (2021-2032) & (K Units)
Figure 10. China Sumatriptan Production (2021-2032) & (K Units)
Figure 11. Japan Sumatriptan Production (2021-2032) & (K Units)
Figure 12. Sumatriptan Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Sumatriptan Consumption (2021-2032) & (K Units)
Figure 15. World Sumatriptan Consumption Market Share by Region (2021-2032)
Figure 16. United States Sumatriptan Consumption (2021-2032) & (K Units)
Figure 17. China Sumatriptan Consumption (2021-2032) & (K Units)
Figure 18. Europe Sumatriptan Consumption (2021-2032) & (K Units)
Figure 19. Japan Sumatriptan Consumption (2021-2032) & (K Units)
Figure 20. South Korea Sumatriptan Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Sumatriptan Consumption (2021-2032) & (K Units)
Figure 22. India Sumatriptan Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Sumatriptan by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Sumatriptan Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Sumatriptan Markets in 2025
Figure 26. United States VS China: Sumatriptan Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Sumatriptan Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Sumatriptan Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Sumatriptan Production Market Share 2025
Figure 30. China Based Manufacturers Sumatriptan Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Sumatriptan Production Market Share 2025
Figure 32. World Sumatriptan Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Sumatriptan Production Value Market Share by Type in 2025
Figure 34.Tablets
Figure 35. Injections
Figure 36. Others
Figure 37. World Sumatriptan Production Market Share by Type (2021-2032)
Figure 38. World Sumatriptan Production Value Market Share by Type (2021-2032)
Figure 39. World Sumatriptan Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Sumatriptan Production Value by Regulatory Status, (USD Million), 2021 & 2025 & 2032
Figure 41. World Sumatriptan Production Value Market Share by Regulatory Status in 2025
Figure 42. Originator Product
Figure 43. Generic Product
Figure 44. World Sumatriptan Production Market Share by Regulatory Status (2021-2032)
Figure 45. World Sumatriptan Production Value Market Share by Regulatory Status (2021-2032)
Figure 46. World Sumatriptan Average Price by Regulatory Status (2021-2032) & (US$/Unit)
Figure 47. World Sumatriptan Production Value by Clinical Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Sumatriptan Production Value Market Share by Clinical Application in 2025
Figure 49. Acute Migraine
Figure 50. Acute Cluster Headache
Figure 51. Others
Figure 52. World Sumatriptan Production Market Share by Clinical Application (2021-2032)
Figure 53. World Sumatriptan Production Value Market Share by Clinical Application (2021-2032)
Figure 54. World Sumatriptan Average Price by Clinical Application (2021-2032) & (US$/Unit)
Figure 55. World Sumatriptan Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World Sumatriptan Production Value Market Share by Application in 2025
Figure 57. Hospital
Figure 58. Retail Pharmacies
Figure 59. Others
Figure 60. World Sumatriptan Production Market Share by Application (2021-2032)
Figure 61. World Sumatriptan Production Value Market Share by Application (2021-2032)
Figure 62. World Sumatriptan Average Price by Application (2021-2032) & (US$/Unit)
Figure 63. Sumatriptan Industry Chain
Figure 64. Sumatriptan Procurement Model
Figure 65. Sumatriptan Sales Model
Figure 66. Sumatriptan Sales Channels, Direct Sales, and Distribution
Figure 67. Methodology
Figure 68. Research Process and Data Source
Figure 1. Sumatriptan Picture
Figure 2. World Sumatriptan Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Sumatriptan Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Sumatriptan Production (2021-2032) & (K Units)
Figure 5. World Sumatriptan Average Price (2021-2032) & (US$/Unit)
Figure 6. World Sumatriptan Production Value Market Share by Region (2021-2032)
Figure 7. World Sumatriptan Production Market Share by Region (2021-2032)
Figure 8. North America Sumatriptan Production (2021-2032) & (K Units)
Figure 9. Europe Sumatriptan Production (2021-2032) & (K Units)
Figure 10. China Sumatriptan Production (2021-2032) & (K Units)
Figure 11. Japan Sumatriptan Production (2021-2032) & (K Units)
Figure 12. Sumatriptan Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Sumatriptan Consumption (2021-2032) & (K Units)
Figure 15. World Sumatriptan Consumption Market Share by Region (2021-2032)
Figure 16. United States Sumatriptan Consumption (2021-2032) & (K Units)
Figure 17. China Sumatriptan Consumption (2021-2032) & (K Units)
Figure 18. Europe Sumatriptan Consumption (2021-2032) & (K Units)
Figure 19. Japan Sumatriptan Consumption (2021-2032) & (K Units)
Figure 20. South Korea Sumatriptan Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Sumatriptan Consumption (2021-2032) & (K Units)
Figure 22. India Sumatriptan Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Sumatriptan by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Sumatriptan Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Sumatriptan Markets in 2025
Figure 26. United States VS China: Sumatriptan Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Sumatriptan Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Sumatriptan Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Sumatriptan Production Market Share 2025
Figure 30. China Based Manufacturers Sumatriptan Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Sumatriptan Production Market Share 2025
Figure 32. World Sumatriptan Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Sumatriptan Production Value Market Share by Type in 2025
Figure 34.Tablets
Figure 35. Injections
Figure 36. Others
Figure 37. World Sumatriptan Production Market Share by Type (2021-2032)
Figure 38. World Sumatriptan Production Value Market Share by Type (2021-2032)
Figure 39. World Sumatriptan Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Sumatriptan Production Value by Regulatory Status, (USD Million), 2021 & 2025 & 2032
Figure 41. World Sumatriptan Production Value Market Share by Regulatory Status in 2025
Figure 42. Originator Product
Figure 43. Generic Product
Figure 44. World Sumatriptan Production Market Share by Regulatory Status (2021-2032)
Figure 45. World Sumatriptan Production Value Market Share by Regulatory Status (2021-2032)
Figure 46. World Sumatriptan Average Price by Regulatory Status (2021-2032) & (US$/Unit)
Figure 47. World Sumatriptan Production Value by Clinical Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Sumatriptan Production Value Market Share by Clinical Application in 2025
Figure 49. Acute Migraine
Figure 50. Acute Cluster Headache
Figure 51. Others
Figure 52. World Sumatriptan Production Market Share by Clinical Application (2021-2032)
Figure 53. World Sumatriptan Production Value Market Share by Clinical Application (2021-2032)
Figure 54. World Sumatriptan Average Price by Clinical Application (2021-2032) & (US$/Unit)
Figure 55. World Sumatriptan Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World Sumatriptan Production Value Market Share by Application in 2025
Figure 57. Hospital
Figure 58. Retail Pharmacies
Figure 59. Others
Figure 60. World Sumatriptan Production Market Share by Application (2021-2032)
Figure 61. World Sumatriptan Production Value Market Share by Application (2021-2032)
Figure 62. World Sumatriptan Average Price by Application (2021-2032) & (US$/Unit)
Figure 63. Sumatriptan Industry Chain
Figure 64. Sumatriptan Procurement Model
Figure 65. Sumatriptan Sales Model
Figure 66. Sumatriptan Sales Channels, Direct Sales, and Distribution
Figure 67. Methodology
Figure 68. Research Process and Data Source
